Fibrosis of extramacular angioid streaks following ranibizumab treatment of subfoveal choroidal neovascularization
March 11th, 2010 Posted by: admin
Similar Posts:
- Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks
- Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks
- EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
- Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy
- Choroidal neovascularization associated with cancer-associated retinopathy
- Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis
- Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation
- Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A
- Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration
- Transient regression of choroidal neovascularization membrane after vitrectomy in age-related macular degeneration with vitreomacular traction syndrome